Clinical trials
Urinary Bladder Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 6 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 19 |
| Completed | 16 |
| Active, not recruiting | 15 |
| Terminated | 3 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Merck Sharp & Dohme LLC | 6 |
| AstraZeneca | 5 |
| Pfizer | 5 |
| Cedars-Sinai Medical Center | 4 |
| Janssen Research & Development, LLC | 4 |
| Bayer | 2 |
| Bristol-Myers Squibb | 2 |
| Daiichi Sankyo | 2 |
| Hoffmann-La Roche | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 55 |
| Carcinoma, Transitional Cell | 14 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Ureteral Neoplasms | 7 |
| Uterine Cervical Neoplasms | 7 |
| Ovarian Neoplasms | 6 |
| Pancreatic Neoplasms | 6 |
| Stomach Neoplasms | 6 |
| Esophageal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
Trials
Showing 51 to 55 of 55. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.